Skip to content

MY DERMA CONSULT

Active
Private limited companyfounded 2019active for 7 yearsSint Huybrechtstraat 111, 1785 Merchtem, BelgiumKBO/BCE: BE 0730.888.169
Summary

MY DERMA CONSULT has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €60,790 and a net result of €50,893. Equity has been growing by about 41% per year since 2019. Its solvency ranks better than 43% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 19-07-2019 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.292.184.036 1785 Merchtem, since 19-07-2019
Financial year end
31 December
Peppol
Reachable since 12-05-2026

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€81,209
▼ 6.8%
Turnover
≈ €180,000
estimated
Profit
€50,893
▼ 15.9%
Equity
€60,790
▲ 1.5%
Total assets
€110,790
▼ 18.8%
Staff
≈ 0.2 FTE
estimated
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.36, cash €55,249Figures for financial year 2025 (filed on 08-07-2026)Size: total assets €110,790Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 56% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 80+11
equity 54.9% of total assets
Liquidity 78+7
short-term debt 45.1% · cash 49.9%
Profitability 100=
return on assets 45.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.36 (1.17 in 2024), below the usual 1.5. Short-term debt is 45.1% and cash 49.9% of total assets. 45.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 44% of them on solvency, 60% on liquidity, 80% on profitability and 41% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.36, cash €55,249
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 08-07-2026)
NBB · annual accounts
lowers risk · Size: total assets €110,790
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
23 days early
2024
17 days early
2023
61 days early
2022
11 days early
2021
16 days early
2020
40 days late
2019
92 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 1 day after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 7 profitable years in a rowprofit 2025: €50,893 7 years View
  • Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View

Recent changes

  1. · Gazette deed Incorporation
All 10 events

Comparable companies

These companies have the same main activity as MY DERMA CONSULT: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €101,000 and €129,000, founded between 2019 and 2020.

CompanyTotal assetsGross margin
MY DERMA CONSULT Merchtem€110,790€81,209
DOCTEUR JERRY COUSIN PEDIATRE Hoeilaart€113,503€88,264
Uvea Tienen€110,165€82,010
Dr. Iris Bombaert Leuven€129,500€85,581
EAS-MED Anderlecht€109,726€85,877
DR. E. VANDER STICHELE, GERIATER Gent€108,726€88,880
Dr. Darcis Dermatology Brussel€100,949€80,010
Full comparison

Key facts about MY DERMA CONSULT

What is the company number of MY DERMA CONSULT?
The company number of MY DERMA CONSULT is 0730.888.169. The VAT number is the same number with BE in front: BE 0730.888.169.
Where is MY DERMA CONSULT based?
The registered office is at Sint Huybrechtstraat 111, 1785 Merchtem.Company details
What does MY DERMA CONSULT do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MY DERMA CONSULT?
The legal form of MY DERMA CONSULT is Private limited company (BV).
When was MY DERMA CONSULT founded?
MY DERMA CONSULT was founded on 19-07-2019.
Is MY DERMA CONSULT still active?
Yes, MY DERMA CONSULT is an active enterprise in the KBO register.
What is the turnover of MY DERMA CONSULT?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €81,209 and 32 comparable companies (NACE 862). It probably lies between €140,000 and €230,000.Financials
Is MY DERMA CONSULT profitable?
In financial year 2025, MY DERMA CONSULT made a profit of €50,893.
Where can I find the annual accounts of MY DERMA CONSULT?
MY DERMA CONSULT filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MY DERMA CONSULT due?
MY DERMA CONSULT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.